The Impact of Age in Patients Undergoing Impella-Assisted Percutaneous Coronary Interventions.

Background: Short-term percutaneous mechanical circulatory support (MCS) devices provide hemodynamic support in cardiogenic shock or during high-risk percutaneous coronary intervention (PCI).

Aims: To assess the impact of age on the clinical and angiographic characteristics and in-hospital outcomes of all patients undergoing PCI with the Impella MCS.

Methods: Data on all patients that underwent PCI with an Impella was divided into three groups according to age: < 65, 65 to < 75 years, and ≥ 75 years.

The impact of sex, body mass index and chronic kidney disease on outcomes following percutaneous coronary intervention.

Objective: This study sought to evaluate 1) the relationship between body mass index (BMI), chronic kidney disease (CKD) and bleeding complications in patients undergoing percutaneous coronary intervention (PCI); and 2) whether CKD modified the effect of BMI on major bleeding and major adverse cardiac and cerebrovascular events (MACCE).

Background: The interaction of CKD, sex and BMI in patients undergoing PCI is unclear.

Methods: Between 2010 and 2018, a total of 31,116 patients underwent PCI at six New York metropolitan area hospitals.

Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patients.

Objective: To assess the clinical characteristics and in-hospital bleeding complications and major adverse cardiac and cerebrovascular events (MACCE) associated with the use of Impella alone or the combination of an intra-aortic balloon pump (IABP) with Impella in cardiogenic shock (CS) patients undergoing percutaneous coronary intervention (PCI).

Methods: All CS patients who underwent PCI and were treated with an Impella mechanical circulatory support (MCS) device were identified. Patients were divided into two groups: having MCS support with Impella alone or with both, IABP and Impella simultaneously (dual MCS group).